News Flash: BYDUREON’s likely FDA approval in two weeks on October 22, 2010

BYDUREON’s likely FDA approval in two weeks on October 22, 2010.

Abbott Pulls Meridia from Market: Abbott announced that it is voluntarily withdrawing the diet drug sibutramine (Meridia) from the U.S. market. The drug has been linked to an increased risk of stroke.